Statistics for Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with HIV-1 Infection
Total visits
| views | |
|---|---|
| Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with HIV-1 Infection | 6 |
Total visits per month
| views | |
|---|---|
| mayo 2024 | 3 |
| junio 2024 | 1 |
| julio 2024 | 0 |
| agosto 2024 | 2 |
| septiembre 2024 | 0 |
| octubre 2024 | 0 |
| noviembre 2024 | 0 |
File Visits
| views | |
|---|---|
| 177_2008_ Cahn_Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with HIV-1 Infection.pdf | 7 |